Family Medicine · Wetumpka, AL
NPI
1356640379
Since 2011
Specialty
Family Medicine
Code 207Q00000X
Group practices
5
Medicare group memberships
Hospitals
5
Hospital affiliations
41 Cambridge Ct
Wetumpka, AL, 36093
Phone (334) 567-3309
Groups this clinician bills Medicare through
Medicare paid, 2024
$145K
6,935 services
Medicare patients, 2024
406
Average age 75
Drug cost, 2024
$2.3M
18,693 prescriptions
Company payments, 2025
$3,389
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Martin A Lyons Jr. was code J1010 (injection, methylprednisolone acetate, 1 mg), 2,444 times for 53 patients. In total Martin A Lyons Jr. billed 6,935 services in 87 codes, and Medicare paid $145K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-06-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 2,444 | 53 | $0.08 | $188 |
| 99214 Office E&M - Established | Office | 979 | 371 | $75.80 | $74K |
| 36415 Venipuncture Blood Collection | Office | 776 | 361 | $7.60 | $5,897 |
| 96372 Injection Administration | Office | 368 | 117 | $7.93 | $2,918 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 259 | 259 | $110.66 | $29K |
| 83036 Blood Count | Office | 252 | 106 | $9.35 | $2,357 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 229 | 72 | $0.07 | $17.04 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 183 | 35 | $0.82 | $151 |
| 71046 X-ray - Chest | Office | 126 | 104 | $18.12 | $2,283 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 125 | 42 | $0.48 | $59.61 |
| 81003 Clinical Chemistry | Office | 114 | 82 | $2.18 | $249 |
| 90662 Vaccine Product | Office | 100 | 100 | $80.08 | $8,008 |
| G0008 Administration of influenza virus vaccine | Office | 98 | 98 | $29.16 | $2,858 |
| 99213 Office E&M - Established | Office | 90 | 74 | $35.03 | $3,153 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 70 | 15 | $0.30 | $21.15 |
By year: 2022 $137K for 4,320 services; 2023 $152K for 4,983 services; 2024 $145K for 6,935 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 776 | 361 | $7.60 | $5,897 |
| 83036 Blood Count | 252 | 106 | $9.35 | $2,357 |
| 81003 Clinical Chemistry | 114 | 82 | $2.18 | $249 |
| 87428 Infectious Agent Detection by DNA/RNA | 30 | 27 | $68.88 | $2,066 |
| 87804 Immunoassay | 27 | 14 | $16.22 | $438 |
| 87811 Immunoassay | 19 | 18 | $40.55 | $770 |
| 87880 Immunoassay | 14 | 12 | $16.20 | $227 |
Medicare prescription drug claims, 2024
In 2024, the drug Martin A Lyons Jr. prescribed most often to Medicare patients was Losartan Potassium, with 726 prescriptions and refills. In total Martin A Lyons Jr. wrote 18,693 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Losartan Potassium Generic | 726 | 2,090 | 212 | $9,793 |
| Levothyroxine Sodium Generic | 629 | 1,706 | 162 | $12K |
| Atorvastatin Calcium Generic | 624 | 1,756 | 188 | $11K |
| Amlodipine Besylate Generic | 612 | 1,704 | 178 | $4,460 |
| Tramadol Hcl Generic | 517 | 517 | 114 | $3,156 |
| Famotidine Generic | 473 | 1,358 | 157 | $8,178 |
| Pantoprazole Sodium Generic | 446 | 1,205 | 146 | $6,332 |
| Rosuvastatin Calcium Generic | 438 | 1,246 | 134 | $15K |
| Gabapentin Generic | 376 | 603 | 96 | $5,021 |
| Duloxetine Hcl Generic | 346 | 971 | 102 | $11K |
| Eliquis Apixaban | 323 | 475 | 53 | $270K |
| Simvastatin Generic | 306 | 875 | 85 | $3,181 |
| Tamsulosin Hcl Generic | 297 | 852 | 102 | $5,941 |
| Prednisone Generic | 294 | 320 | 210 | $736 |
| Omeprazole Generic | 287 | 857 | 86 | $5,849 |
Brand drugs: 2,364 claims; generic drugs: 16,287 claims; opioid claims: 862.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Martin A Lyons Jr. $3,389 ($3,389 in general payments such as food, travel and fees) from 29 companies. The largest payer was Neurocrine BioSciences, Inc. with $672.
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. NBIX | 28 | $672 |
| Novo Nordisk Inc NVO | 19 | $359 |
| AstraZeneca Pharmaceuticals LP AZN | 14 | $312 |
| Pfizer Inc. PFE | 14 | $270 |
| GlaxoSmithKline, LLC. GSK | 13 | $223 |
| Abbvie Inc. ABBV | 16 | $214 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 10 | $189 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $162 |
| Lilly USA, LLC LLY | 9 | $141 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 7 | $113 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.